Nadifloxacin downregulates the production of matrix metalloproteinases in the human epidermal keratinocyte cell line HaCaT.
Satomi
S
Hosoda
Mayumi
M
Komine
Masaru
M
Karakawa
Hidetoshi
H
Tsuda
Mamitaro
M
Ohtsuki
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002460:Cell Line; D015536:Down-Regulation / Q000187:drug effects*; D004817:Epidermis / Q000187:drug effects* / Q000201:enzymology; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects* / Q000201:enzymology; D020782:Matrix Metalloproteinases / Q000096:biosynthesis*; D011807:Quinolizines / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D011807:Quinolizines; C062127:nadifloxacin; D020782:Matrix Metalloproteinases